PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN ADVANCED MALIGNANT-MELANOMA

被引：4
|
作者：
HOST, H
JOSS, R
PINEDO, H
BRUNTSCH, U
CAVALLI, F
RENARD, G
VANGIABBEKE, M
ROZENCWEIG, M
机构：
[1] DET NORSKE RADIUM HOSP,OSLO 3,NORWAY
[2] INSELSPITAL,INST MED ONKOL,CH-3010 BERN,SWITZERLAND
[3] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,1081 HV AMSTERDAM,NETHERLANDS
[4] MED KLIN NURNBERG,NURNBERG KLIN,D-8500 NURNBERG,FED REP GER
[5] OSPED SAN GIOVANNI,SERV ONCOL,CH-6500 BELLINZONA,SWITZERLAND
[6] EUROPEAN ORG RES TREATMENT CANC,CTR DATA,B-1000 BRUSSELS,BELGIUM
[7] INST JULES BORDET,SERV MED,B-1000 BRUSSELS,BELGIUM
[8] INST JULES BORDET,HJ TAGNON INVEST CLIN LAB,B-1000 BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1983年 / 19卷 / 02期
关键词：
D O I：
10.1016/0277-5379(83)90430-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：295 / 298
页数：4
相关论文
共 50 条
  • [41] COMBINATION OF CISPLATIN, VINDESINE, AND DACARBAZINE IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF THE EORTC MALIGNANT-MELANOMA COOPERATIVE GROUP
    VERSCHRAEGEN, CF
    KLEEBERG, UR
    MULDER, J
    RUMKE, P
    TRUCHETET, F
    CZARNETZKI, B
    ROZENCWEIG, M
    THOMAS, D
    SUCIU, S
    CANCER, 1988, 62 (06) : 1061 - 1065
  • [42] PHASE-II TRIAL WITH N-(PHOSPHONOACETYL)-L-ASPARTATE (PALA) IN ADVANCED MALIGNANT-MELANOMA
    KLEEBERG, UR
    KISNER, D
    RUMKE, P
    MULDER, JH
    REVUZ, J
    PINEDO, H
    MACHER, E
    CZARNETZKI, B
    THOMAS, D
    ROZENCWEIG, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 529 - 529
  • [43] PHASE-II STUDY OF MITOLACTOL AND SEMUSTINE COMBINATION CHEMOTHERAPY FOR ADVANCED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    SCHUTT, AJ
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1425 - 1426
  • [44] A PHASE-II TRIAL OF THE USE OF RECOMBINANT ALPHA-2 INTERFERON AND CIMETIDINE IN ADVANCED MALIGNANT-MELANOMA
    MUGHAL, TI
    ROBINSON, WA
    THOMAS, MR
    HERMON, B
    JOHNSON, MM
    CLINICAL RESEARCH, 1984, 32 (02): : A420 - A420
  • [45] COMBINED TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH COUMARIN AND CIMETIDINE - A PHASE-II STUDY
    PEDERSEN, L
    ROSE, C
    LANGVAD, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (02) : 178 - 179
  • [46] PHASE-II STUDY OF THE COMBINATION OF VINBLASTINE, BLEOMYCIN, AND CISPLATIN IN ADVANCED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    SCHUTT, AJ
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1982, 66 (03): : 567 - 569
  • [47] PHASE-II TRIAL OF VM-26 IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BELLET, RE
    CATALANO, RB
    MASTRANGELO, MJ
    BERD, D
    KOONS, LS
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 445 - 447
  • [48] PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA
    NOLTE, H
    GJEDDE, SB
    LINDEGAARDMADSEN, E
    BERGH, J
    BLOMQUIST, E
    MOURIDSEN, HT
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 655 - 657
  • [49] PHASE-II STUDY OF MITOLACTOL IN METASTATIC MALIGNANT-MELANOMA
    SIMMONDS, MA
    LIPTON, A
    HARVEY, HA
    ELLISON, N
    WHITE, DS
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 65 - 67
  • [50] PHASE-II STUDY OF MITOMYCIN IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    EDMONSON, JH
    AHMANN, DL
    CHANG, M
    CANCER TREATMENT REPORTS, 1985, 69 (12): : 1451 - 1452
12345